IL17A and psoriasis: Salvianolic acid B-containing microemulsion alleviated severity of imiquimod-induced psoriasis-like dermatitis, inhibited IL-23/IL-17 cytokines, reduced acanthosis, inhibited epidermal proliferation, and increased skin hydration [22].